Anaplastic Pleomorphic Xanthoastrocytoma

Anaplastic Pleomorphic Xanthoastrocytoma — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 67%
Top sponsor: Jazz Pharmaceuticals
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03919071	Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma	active not recruiting	Phase 2	58	National Cancer Institute (NCI)NIH	2	Jul 10, 2026	clinicaltrials
NCT03973918	Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG(BRAF)	terminated	Phase 2	5	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1